Sirona Biochem Corp.

10/24/2024

Stonegate Capital Partners has initiated coverage on Sirona Biochem (TSX-V: SBM), highlighting our innovative anti-aging compound GlycoProteMim™ and our path to profitability in 2025.

Read the full Initiation of Coverage Report: https://stonegateinc.com/download/sbm-initiation/?wpdmdl=1100&refresh=67184a3a592911729645114

09/27/2024

Sirona Biochem is on track for profitability by 2025 with the global launch of our groundbreaking GlycoProteMim™ anti-aging serum. Our innovative product is set to revolutionize the skincare market, and we’re excited to share our latest updates.

Read the Full Release here: https://www.sironabiochem.com/sirona-biochem-poised-for-profitability-in-2025-with-anti-aging-product-rollout/

06/18/2024

Our breakthrough anti-aging ingredient, GlycoProteMim™, has been prominently featured in Stonegate Healthcare’s latest research report on innovative anti-aging skincare treatments!

Learn more about how our breakthrough ingredient stands out among the other top treatments in the $12.5 billion anti-aging market.

Download Stonegate Healthcare’s Comprehensive Research Report - https://shp.reportablenews.com/pr/stonegate-healthcare-partners-announces-publication-of-thematic-report-on-anti-aging-dermatology-innovations

06/06/2024

This year's is proving to be our most impactful yet. With each productive encounter, is advancing and cultivating fresh collaborations.

06/04/2024

Excited to kick off by engaging in productive discussions and sharing updates with our valued partners. Looking forward to deepening our collaborations and exploring new opportunities together.

05/29/2024

With Stonegate Healthcare's support, Howard Vericco is ready to dive into discussions at on the future of biotech and the crucial role of Sirona Biochem's breakthrough anti-aging active ingredient, GlycoProtemim.

Learn More About GlycoProtemim - https://glycoprotemim.com/

05/27/2024

Counting down the days until ! We are excited to join industry leaders, researchers, and investors worldwide to discuss the latest advancements in cosmetic science and biotech.

05/24/2024

Stonegate Healthcare has set up nearly 30 confirmed meetings for Sirona Biochem at the upcoming conference. Looking forward to connecting with industry peers and potential partners at the event.

https://convention.bio.org/

05/22/2024

Sirona Biochem CEO, Howard Verrico, will be attending , the largest biotech event of the year, in San Diego, California. Stay tuned for updates on his meetings and insights from the conference!

About Bio 2024 - https://convention.bio.org/about-bio

05/07/2024

Sirona Biochem Partners with US-based Capital Markets Adviser Stonegate Healthcare to Expand Investment and Business Opportunities.

Read Full Press Release Here: https://www.globenewswire.com/en/news-release/2024/05/07/2876691/0/en/Sirona-Biochem-Engages-Stonegate-Healthcare-Partners.html

04/08/2024

We are pleased to provide major updates ranging from our latest AGM to the closure of our financing round and the upcoming launch of our GlycoProteMim™ product line.

Read our full press release: https://www.globenewswire.com/news-release/2024/04/08/2858883/0/en/SIRONA-BIOCHEM-Corporate-Update-April-2024.html

Advancing Chemistry, Enhancing Health Our proprietary platform enables us to develop safer and more effective active ingredients for next-generation medical products and treatments. Our disruptive patented compounds are licensed by pharmaceutical companies worldwide. Download our latest Investor Pre...

04/02/2024

Sirona Biochem was in attendance at the recent PCHI Shanghai 2024 trade fair. Board member Jason Tian was at the fair to showcase our cutting-edge GlycoProteMim™ technology and open dialogue for international partnerships.